Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2017

Open Access 01-12-2017 | Research article

The changing epidemiology and clinical features of infective endocarditis: A retrospective study of 196 episodes in a teaching hospital in China

Authors: Wan Zhu, Qian Zhang, Jingping Zhang

Published in: BMC Cardiovascular Disorders | Issue 1/2017

Login to get access

Abstract

Background

Infective endocarditis is an uncommon but life-threatening infectious disease. To our knowledge, current investigations of the characteristics of infective endocarditis in our region are scarce. In this study, we aimed to investigate the changes in the epidemiology and clinical features of infective endocarditis.

Methods

A retrospective analysis of clinical data was performed using 196 infective endocarditis cases diagnosed between June 2004 and December 2012 at The First Affiliated Hospital of China Medical University. A comparative analysis of clinical risk factors was also included.

Results

The mean age of the patient cohort was 43.5 (29.0–55.8) years old. Of the 196 cases studied, 128 cases (65.3%) were left native valve infective endocarditis, 13 cases (6.6%) were left prosthetic valve infective endocarditis, and 47 cases (24%) were right valve infective endocarditis. In addition to natural valve endocarditis, many patients also exhibited various types of cardiopathy: 72 cases (36.7%) had congenital cardiovascular malformations, 37 cases (18.9%) had idiopathic mitral valve prolapse and 31 cases (15.8%) had no significant cardiac disease. The primary clinical manifestations that were observed included 168 cases with fever (85.7%), 131 cases with anemia (66.8%), 114 cases with hematuria (58.2%) and 58 cases with splenomegaly (29.6%). Positive blood cultures were detected in 96 cases (49%); the most commonly detected organism was Streptococcus viridans (41 cases; 42.7%), followed by 18 cases (18.8%) of Staphylococcus aureus and 10 cases (10.4%) of Enterococcus. With respect to risk factors, infection with Staphylococcus aureus or gram-negative bacilli (OR = 18.81, 95%CI = 2.39–148.2), congestive heart failure (OR = 8.854, 95%CI = 1.34–54.7), diabetes (OR = 7.224, 95%CI = 1.17–44.7) and age ≥ 60 years (OR = 6.861, 95%CI = 0.94–50.1) were major prognostic risk factors.

Conclusion

Infective endocarditis is more common than previously believed, but there are regional differences with respect to the epidemiological and clinical characteristics of infective endocarditis, and its etiology is diverse and complicated. Our study of the clinically diagnosed cases of infective endocarditis verified the regional characteristics of infective endocarditis using a straightforward retrospective analysis. The geographic variations we observed in the study will be of important value to clinical diagnosis in our region.
Literature
1.
go back to reference Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009; 30:2369–413. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009; 30:2369–413.
2.
go back to reference Math RS, Sharma G, Kothari SS, Kalaivani M, Saxena A, Kumar AS, et al. Prospective study of infective endocarditis from a developing country. Am Heart J. 2011;162:633–8.CrossRefPubMed Math RS, Sharma G, Kothari SS, Kalaivani M, Saxena A, Kumar AS, et al. Prospective study of infective endocarditis from a developing country. Am Heart J. 2011;162:633–8.CrossRefPubMed
3.
4.
go back to reference Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on Endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–73.CrossRefPubMedPubMedCentral Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on Endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–73.CrossRefPubMedPubMedCentral
5.
go back to reference Polewczyk A, Janion M, Podlaski R, Kutarski A. Clinical manifestations of lead-dependent infective endocarditis: analysis of 414 cases. Eur J Clin Microbiol Infect Dis. 2014;33:1601–8.CrossRefPubMedPubMedCentral Polewczyk A, Janion M, Podlaski R, Kutarski A. Clinical manifestations of lead-dependent infective endocarditis: analysis of 414 cases. Eur J Clin Microbiol Infect Dis. 2014;33:1601–8.CrossRefPubMedPubMedCentral
6.
go back to reference Fernández-Hidalgo N, Tornos MP. Epidemiology of infective endocarditis in Spain in the last 20 years. Rev Esp Cardiol (Engl Ed). 2013;66:728–33.CrossRef Fernández-Hidalgo N, Tornos MP. Epidemiology of infective endocarditis in Spain in the last 20 years. Rev Esp Cardiol (Engl Ed). 2013;66:728–33.CrossRef
7.
go back to reference Korem M, Israel S, Gilon D, Cahan A, Moses AE, Block C, et al. Epidemiology of infective endocarditis in a tertiary-center in Jerusalem: a 3-year prospective survey. Eur J Intern Med. 2014;25:550–5.CrossRefPubMed Korem M, Israel S, Gilon D, Cahan A, Moses AE, Block C, et al. Epidemiology of infective endocarditis in a tertiary-center in Jerusalem: a 3-year prospective survey. Eur J Intern Med. 2014;25:550–5.CrossRefPubMed
8.
go back to reference Kanafani ZA, Mahfouz TH, Kanj SS. Infective endocarditis at a tertiary care centre in Lebanon: predominance of streptococcal infection. J Inf Secur. 2002;45:152–9. Kanafani ZA, Mahfouz TH, Kanj SS. Infective endocarditis at a tertiary care centre in Lebanon: predominance of streptococcal infection. J Inf Secur. 2002;45:152–9.
9.
go back to reference Lee MR, Chang SA, Choi SH, Lee GY, Kim EK, Peck KR, et al. Clinical features of right-sided infective endocarditis occurring in non-drug users. J Korean Med Sci. 2014;29:776–81.CrossRefPubMedPubMedCentral Lee MR, Chang SA, Choi SH, Lee GY, Kim EK, Peck KR, et al. Clinical features of right-sided infective endocarditis occurring in non-drug users. J Korean Med Sci. 2014;29:776–81.CrossRefPubMedPubMedCentral
10.
go back to reference Borde JP, Sitaru G, Kopp WH, Ruhparwar A, Ehlermann P, Lasitschka F, et al. Heart transplantation as salvage therapy for progressive prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis (MRSE). J Cardiothorac Surg. 2016;11:100.CrossRefPubMedPubMedCentral Borde JP, Sitaru G, Kopp WH, Ruhparwar A, Ehlermann P, Lasitschka F, et al. Heart transplantation as salvage therapy for progressive prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis (MRSE). J Cardiothorac Surg. 2016;11:100.CrossRefPubMedPubMedCentral
11.
go back to reference Cancan Gursul N, Vardar I, Demirdal T, Gursul E, Ural S, Yesil M. Clinical and microbiological findings of infective endocarditis. J Infect Dev Ctries. 2016;10:478–87.CrossRefPubMed Cancan Gursul N, Vardar I, Demirdal T, Gursul E, Ural S, Yesil M. Clinical and microbiological findings of infective endocarditis. J Infect Dev Ctries. 2016;10:478–87.CrossRefPubMed
12.
go back to reference Castillo JC, Anguita MP, Ruiz M, Pena L, Santisteban M, Puentes M, et al. Changing epidemiology of native valve infective endocarditis. Rev Esp Cardiol. 2011;64:594–8.CrossRefPubMed Castillo JC, Anguita MP, Ruiz M, Pena L, Santisteban M, Puentes M, et al. Changing epidemiology of native valve infective endocarditis. Rev Esp Cardiol. 2011;64:594–8.CrossRefPubMed
13.
go back to reference Lopez J, Fernandez-Hidalgo N, Revilla A, Vilacosta I, Tornos P, Almirante B, et al. Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis. Heart. 2011;97:1138–42.CrossRefPubMed Lopez J, Fernandez-Hidalgo N, Revilla A, Vilacosta I, Tornos P, Almirante B, et al. Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis. Heart. 2011;97:1138–42.CrossRefPubMed
14.
go back to reference Chambers ST, Murdoch D, Morris A, Holland D, Pappas P, Almela M, et al. HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One. 2013;8:e63181.CrossRefPubMedPubMedCentral Chambers ST, Murdoch D, Morris A, Holland D, Pappas P, Almela M, et al. HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One. 2013;8:e63181.CrossRefPubMedPubMedCentral
Metadata
Title
The changing epidemiology and clinical features of infective endocarditis: A retrospective study of 196 episodes in a teaching hospital in China
Authors
Wan Zhu
Qian Zhang
Jingping Zhang
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2017
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-017-0548-8

Other articles of this Issue 1/2017

BMC Cardiovascular Disorders 1/2017 Go to the issue